Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines. The Phase 1-ready asset was licensed from China-based DartsBio Pharmaceuticals.
The post Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic appeared first on MedCity News.
Frank Charles, a pet-resort owner and former five-term mayor of St. Augustine, Florida, wanted a tattoo. He just wasn’t sure that he could take the […]
When I was at HLTH last October Bradley Bostic invited me on his BoomBostic Health podcast. I was in the mood for ranting about the […]
For a moment, the threat of guac-ocalypse loomed over America. Had President Donald Trump’s proposed tariffs on Mexico and Canada gone into effect, the prices […]